Guru Sonpavde, GU Oncology and Phase I Clinical Trials Director, Chair of Bladder Cancer Research at AdventHealth Central Florida, shared on LinkedIn:
“Bladder Cancer Center at Adventhealth Cancer Institute, Orlando, Florida.
Comprehensive bladder cancer care from our multidisciplinary team including urologists, radiation oncologists, medical oncologists – bringing cutting edge bladder cancer and urothelial carcinoma therapy to central Florida and beyond including surgery, robotic surgery, radiation, clinical trials, precision oncology, immunotherapy, targeted therapy, radioligand therapeutics, antibody drug conjugates, ctDNA and molecular profile-guided customized therapy.”
Read also “Enfortumab Vedotin–Pembrolizumab Improves Survival in Cisplatin-Eligible Bladder Cancer” on OncoDaily.
